AGILENT TECHNOLOGIES, INC. A

Latest FY: 2025 Healthcare Diagnostics & Research
Market Price $148.44
Market Cap $42.16B
P/E Ratio 32.48
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑6.7% YoY
$6.95B
3-Yr CAGR: 0.5%
Net Income ↑1.1% YoY
$1.30B
Net Margin: 18.8%
Free Cash Flow ↓-16.1% YoY
$1.15B
FCF Yield: 2.73%
EPS (Diluted) ↑3.2% YoY
$4.57
Basic: $4.59
Return on Equity Efficiency
19.3%
ROA: 28.4%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (A)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $4,202.0M $2,197.0M $462.0M $1.40 $793.0M $654.0M
FY 2017 $4,472.0M +6.4% $2,409.0M $684.0M +48.1% $2.10 +50.0% $889.0M $713.0M +9.0%
FY 2018 $4,914.0M +9.9% $2,687.0M $316.0M -53.8% $0.97 -53.8% $1,087.0M $910.0M +27.6%
FY 2019 $5,163.0M +5.1% $2,805.0M $1,071.0M +238.9% $3.37 +247.4% $1,021.0M $866.0M -4.8%
FY 2020 $5,339.0M +3.4% $2,837.0M $719.0M -32.9% $2.30 -31.8% $921.0M $802.0M -7.4%
FY 2021 $6,319.0M +18.4% $3,407.0M $1,210.0M +68.3% $3.94 +71.3% $1,485.0M $1,297.0M +61.7%
FY 2022 $6,848.0M +8.4% $3,722.0M $1,254.0M +3.6% $4.18 +6.1% $1,312.0M $1,021.0M -21.3%
FY 2023 $6,833.0M -0.2% $3,465.0M $1,240.0M -1.1% $4.19 +0.2% $1,772.0M $1,474.0M +44.4%
FY 2024 $6,510.0M -4.7% $3,535.0M $1,289.0M +4.0% $4.43 +5.7% $1,751.0M $1,373.0M -6.9%
FY 2025 $6,948.0M +6.7% $3,643.0M $1,303.0M +1.1% $4.57 +3.2% $1,559.0M $1,152.0M -16.1%
$

Valuation

Market Price $148.44
Market Cap $42.16B
Enterprise Value $43.43B
P/E Ratio 32.48
P/B Ratio 6.22
FCF Yield 2.73%
Dividend Yield 0.67%
Shares Outstanding 282,431,900
%

Profitability & Margins

Gross Margin 52.43%
Operating Margin 21.29%
Net Margin 18.75%
Return on Equity (ROE) 19.33%
Return on Assets (ROA) 28.36%
Asset Turnover 1.51x
Revenue 3-Yr CAGR 0.48%
🛡️

Financial Health & Liquidity

Current Ratio 1.96
Cash Ratio 0.76
Debt / Equity 0.452
Debt / Assets 0.664
Cash & Equivalents $1.79B
Total Debt $3.05B
Book Value / Share $23.87
💧

Cash Flow Efficiency

Operating Cash Flow $1.56B
Capital Expenditures (CapEx) $407.00M
Free Cash Flow $1.15B
OCF / Revenue 22.44%
FCF / Revenue 16.58%
FCF 3-Yr CAGR 4.11%
🏷️

Per Share Metrics

EPS (Diluted) $4.57
EPS (Basic) $4.59
Dividends / Share $0.99
Book Value / Share $23.87
EPS YoY Growth 3.16%
🏛️

Balance Sheet (FY 2025)

Total Assets $4.59B
Total Liabilities $2.35B
Stockholders' Equity $6.74B
Current Assets $4.59B
Current Liabilities $2.35B